Vir Biotechnology Inc (VIR) — Cash Flow Reinvestment Rate

Latest as of December 2022: 4.72x

Vir Biotechnology Inc (VIR) has a Cash Flow Reinvestment Rate of 4.72x as of December 2022, reinvesting $165.73 Million (capex $12.60 Million plus investments $-153.13 Million) from operating cash flow of $35.13 Million. Explore Vir Biotechnology Inc capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

4.72x
(Capex + Investments) / Operating CF

Total Reinvested

$165.73 Million
Capex + Investments

Operating Cash Flow

$35.13 Million
USD

Capital Expenditures

$12.60 Million
USD

Vir Biotechnology Inc Cash Flow Reinvestment Rate (2022–2022)

Historical reinvestment intensity for Vir Biotechnology Inc across 1 annual periods. Also explore Vir Biotechnology Inc (VIR) total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Vir Biotechnology Inc (2022–2022)

Year-by-year capital reinvestment analysis for Vir Biotechnology Inc. For live market cap and broader valuation context, see market value of Vir Biotechnology Inc.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2022 0.76x $1.26 Billion $1.66 Billion $68.01 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow